mabthera-ra.com — A group of 12 leading rheumatology experts across the EU and Canada recognised the current unmet medical need in rheumatoid arthritis and concluded that rituximab constitutes a significant therapeutic advance for the treatment of patients with RA. The consensus statement follows a review of data from randomised, controlled trials of rituximab in RA